


<!DOCTYPE html>
<html lang="en">
<head><script>(function (w, d, s, l, i) {
 w[l] = w[l] || []; w[l].push({
  'gtm.start':
  new Date().getTime(), event: 'gtm.js'
 }); var f = d.getElementsByTagName(s)[0],
 j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
})(window, document, 'script', 'dataLayerCIT', 'GTM-W6MJHWF');</script>
	<meta charset="utf-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<meta name="description" content="View efficacy data for Sandostatin&#174; LAR Depot (octreotide acetate) for injectable suspension for the treatment of severe diarrhea and flushing associated with metastatic carcinoid tumors. See full Prescribing and Safety Information." />
	<meta name="keywords" />
	<meta name="format-detection" content="telephone=no">
	<meta name="viewport" content="width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no">

	<title>Sandostatin&#174; LAR Depot (octreotide acetate) for injectable suspension Efficacy | Health Care Professional Site</title>

		<script language="javascript" type="text/javascript" src="http://www.pharma.us.novartis.com/privacy-lightbox/privacy-update-controller.js"></script>
		<script>



			var displayGlobalPPDisclaimer = false;
		</script>


	<link href="../../../../bundles/css/master%3Fv=DFPHbovhUMiL9Dn52heMUNXymBxWvano9tAsQ64HmSY1.css" rel="stylesheet"/>

	<script src="../../../../bundles/script/jquery%3Fv=4Fx6N4x0ohHzU3HBQJk1GtgRoUo_IXc-CWFU9ADPAB81"></script>



	

  <!-- V4 JS core and at least one video plugin is required. Plugins such as skin, discovery and Advertising need to be loaded separately -->
  <script src="http://player.ooyala.com/static/v4/stable/4.8.5/core.min.js"></script>
  <script src="http://player.ooyala.com/static/v4/stable/4.8.5/video-plugin/main_html5.min.js"></script>
  <script src="http://player.ooyala.com/static/v4/stable/4.8.5/video-plugin/osmf_flash.min.js"></script>
 <!-- <script src="//player.ooyala.com/static/v4/stable/4.6.9/video-plugin/bit_wrapper.min.js"></script> -->
  <!-- Change these html5-skin.min.css and html5-skin.min.js to your local build if necessary -->
  <script src="http://player.ooyala.com/static/v4/stable/4.8.5/skin-plugin/html5-skin.min.js"></script>
  <link rel="stylesheet" href="http://player.ooyala.com/static/v4/stable/4.8.5/skin-plugin/html5-skin.min.css" />


 <link href="../../../../bundles/css/brands%3Fv=MJ1cSwv0ph-T8cA6caKmdNsA7L_OcnSUI801YYiuxLo1.css" rel="stylesheet"/>

 

  <style type="text/css">
 .brandColor, .left-teaser a, .uso-brand-detailmenu li{
  color:#19a2b1;
 }
 a.brandColor, a.brandColor:hover, a.brandColor:active {
  color:#19a2b1;
 }
 .brandBackColor {
  background-color:#19a2b1;
 }
 .select-indication a.brandColor,
 .select-indication a.brandColor:hover {
  color: #19a2b1;
 }
 .geo-panel .glyphicon {
  color: #19a2b1;
 }
 .uso-accordion-title:after {
  border-color: #19a2b1 !important;
 }

  </style>


		




		<script>
			window.dataLayerOnco = window.dataLayerOnco || [];

			var preDataLayerOnco = {"environment":"STAGE","department":undefined,"indication":"carcinoid-syndrome","brand":"sandostatin-lar-depot","type":undefined,"sectionLevel1":"products","sectionLevel2":"carcinoid-syndrome","sectionLevel3":"efficacy","status":undefined,"name":"products : sandostatin-lar-depot : carcinoid-syndrome : efficacy"};
			preDataLayerOnco.department = 'oncology';
			preDataLayerOnco.type = 'hcp';
			preDataLayerOnco.status = 200;
			dataLayerOnco.push({
				'page':preDataLayerOnco
			});
		</script>
		<!-- Google Tag Manager -->
		<script>
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
		new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
		j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
		'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
		})(window,document,'script','dataLayerOnco','GTM-PH7LL77');</script>
		<!-- End Google Tag Manager -->


</head>
<body>

		<!-- Google Tag Manager -->
		<noscript>
			<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PH7LL77" height="0" width="0" style="display:none;visibility:hidden"></iframe>
		</noscript>
		<!-- End Google Tag Manager -->

	<script type="text/javascript">

  $(document).ready(function () {

/**/
// global vars
var path = window.location.pathname.split('/'),
pageName,
channel,
brandProduct,
campaign;

/**/
// URL / dataLayer functions
function getQueryVariable(variable) {
 var query = window.location.search.substring(1);
 var vars = query.split('&');
 for (var i = 0; i < vars.length; i++) {
  var pair = vars[i].split('=');
  if (decodeURIComponent(pair[0]) == variable) {
return decodeURIComponent(pair[1]);
  } else {
return "";
  }
 }
}

function dataLayerFunction() {
 $('a').not('#brand-detail-page .uso-tab-menu a').not('.onePageTemplatePage .uso-tab-menu a').on('click', function () {
  var $this = $(this);
  if ($this.parents('.selectpicker').length == 0) {

var pattern = /^.*\.(docx|DOCX|xlsx|XLSX|xls|doc|DOC|pdf|PDF)$/;
if ($this.attr('href') !== undefined) {
 var ext = $this.attr('href').match(pattern);

 if (ext != null) {
  if (ext[1] == 'docx' || 'DOCX' || 'xlsx' || 'XLSX' || 'xls' || 'doc' || 'DOC' || 'pdf' || 'PDF') {
fileDownload = $this.attr('href');
dataLayer.page.fileDownload = fileDownload;
  }
 }
}
  }
 })

 $('.research-landing-page a').on('click', exitLink);
 $('#uso-product-page a').on('click', exitLink)
 function exitLink() {
					var href = $(this).attr('href');
					if (typeof href != 'undefined') {
						var boolExternalLink = isExternalLink(href);
						if (boolExternalLink) {
							dataLayer.page.exitLink = href;
						}
					}
 }
 function isExternalLink(href) {
  var dataTarget = $(this).data('target');
  var domain = href.split("?");
  if (domain[0].indexOf('http') != -1 && domain[0].indexOf(window.location.hostname) == -1 && dataTarget != "none") {
return true;
  } else {
return false;
  }
 }
}

/**/
// set dataLayer vars
if (path.length == 2) {
 pageName = "home";
 channel = "";
} else {

 var hasEndSlash = (window.location.pathname.lastIndexOf('/') == window.location.pathname.length - 1);
 if (hasEndSlash) {
  if (path[path.length - 1] == "") {
path.pop();
  }
 }
 path = path.slice(1);
 pageName = path.join(':').toLowerCase();
 if (path.length == 1) {
  channel = pageName;
 } else {
  channel = path[0];
 }
}
// sets the last url location value to brandProduct
brandProduct = window.location.pathname.split('/');
brandProduct = brandProduct[brandProduct.length - 2];
if (brandProduct == "")
 brandProduct = "home";

campaign = getQueryVariable("site");

dataLayerFunction();

/**/
// build dataLayer
dataLayer = {
 page: {
  pageName: 'hcp' + ':' + pageName,
  channel: channel,
  pageCategory: 'HCP',
  eVar20: brandProduct,
  campaign: campaign
 }
};

  });
	</script>
	<main>
				



		
		<a href="http://usoncohcp-web.stage.novartis.episerverhosting.com/"></a>
		<a href="http://usoncohcp-web.stage.novartis.episerverhosting.com/"></a>
		
		<a href="http://localhost:38015/"></a>
		<a href="http://localhost:38015/"></a>
		
		<a href="http://localhost:38015/?link=hgjhgjhg"></a>
		<a href="http://localhost:38015/?link=hgjhgjhg"></a>

		<div id="movingOnDisclaimer" class="modal fade" data-backdrop="static">
			<div class="modal-dialog">
				<div class="modal-content">
					<div class="modal-header">
						<button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
						<img class="center-block" src="../../../../Static/img/global/uso-logo-header.png" />
					</div>
					<div class="modal-body">

						<p>
							We’re moving on!<br />
							Join us at <span data-dismiss="modal" class="hcpLink">www.hcp.novartis.com</span>—our new location for health care professionals to find product, access, and medical information. Now you can find the tools you need to help manage your patients, all in one place!
						</p>
						<p>You’ll have access to the site in a moment, or click <span class="hcpLink" data-dismiss="modal">continue</span> to  close this message and advance directly to the site.</p>

					</div>
					<div class="modal-footer">
						<div class="disclaimer-omap">
							12/15 ONC-1130276
						</div>
					</div>
				</div>
			</div>
		</div>

		<div id="uso-page">
			
			<div><div>


<div class="container-fluid container-header">
 <nav class="navbar navbar-default">
  <div class="uso-mobile-nav-header visible-xs-block visible-sm-block visible-md-block">This site is for US health care professionals only.</div>

  <div style="position:relative;">
<div id="uso-mobile-search-block">
 <input id="uso-mobile-search-input" type="text" class="uso-search-header-mobile clearable" placeholder="Search" />
</div>
<div class="navbar-header  ">
 <div class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar" data-link="/">
  <span class="sr-only">Toggle navigation</span>
  <img class="uso-nrts-logo" src="../../../../globalassets/novartis-logo-111516.svg" alt="Novartis logo" />
 </div>
 <a class="navbar-brand visible-lg-block visible-lg-block" href="http://usoncohcp-admin.stage.novartis.episerverhosting.com/" title="Novartis logo"><img class="uso-nrts-logo" src="../../../../globalassets/novartis-logo-111516.svg" alt="Novartis logo" /></a>
	
						<button id="uso-brandheader-mobile-btn" class="hidden-lg navbar-toggle collapsed" type="button" data-toggle="collapse" data-target="#uso-brandheader-mobile-menu nav">
							<span class="sr-only">Toggle navigation</span>
							<span class="icon-bar"></span>
							<span class="icon-bar"></span>
							<span class="icon-bar"></span>
						</button>
					<div class="tagline">
						<span class="uso-navbar-brand-desc visible-lg-inline-block">This site is for US health care professionals only.</span>
					</div>

  <div id="uso-brandheader-mobile-menu" class="hidden-lg">
<nav class="navbar-collapse bs-navbar-collapse collapse" aria-expanded="false">
  <p class="uso-brandheader-indication">For: Severe Diarrhea and Flushing Associated With Carcinoid Syndrome</p>
 <ul class="nav navbar-nav">
  <li><a href="index.html">Efficacy</a></li>
  <li><a href="../safety-profile/index.html">Safety Profile</a></li>
  <li><a href="../dosing-administration/index.html">Dosing &amp; Administration</a></li>
  <li><a href="../nurse-center/index.html">On-Demand Training &amp; Resources</a></li>
  <li><a href="../mechanism-of-action/index.html">Mechanism of Action</a></li>
  <li><a href="../access/index.html">Access</a></li>
  <li><a href="../patient-resources/index.html">Patient Resources</a></li>
 </ul>
</nav>
  </div>
		</div>
 </div>
</nav>
</div>
<input id="uso-hidden-search-page-url" type="hidden" value="/search/" /></div></div>
			





<div class="container">
 <div class="row brandHeader">
  <div class="col-lg-6 col-md-6 col-xs-12" title="Sandostatin&#174; LAR Depot (octreotide acetate) for injectable suspension logo">
<a class="backLink" href="../index.html" title="Sandostatin&#174; LAR Depot (octreotide acetate) for injectable suspension logo"><i class="fa fa-angle-left"></i></a>
<img class="brandLogo" src="../../../../globalassets/products/sandostatin-lar/sandostatin-header-logo-2019-01-24.png" alt="Sandostatin&#174; LAR Depot (octreotide acetate) for injectable suspension logo" />
  </div>
<div class="col-lg-6 col-md-6 col-xs-12 indicationsSelector clearfix">
 <b>For:</b>

 <div id="selector-container">
  <div class="current-indication">
<span>Severe Diarrhea and Flushing Associated With Carcinoid Syndrome</span>
  </div>
  <ul class="select-indication">

  <li class=""><a class="" href="../../acromegaly/index.html" target="_self" data-target="">Acromegaly</a></li>
  </ul>
 </div>
</div>

 </div>
</div>
<div class="container-fluid">
 <div class="row rowIsi ">
  <div class="col-lg-12 isiLinkContainer brandBackColor">
 <a href="index.html#important-safety-info" class="isiLink arrow" >
IMPORTANT SAFETY INFORMATION AND INDICATION </a>
  </div>
 </div>
 
</div>

<div class="container">
 <div class="hidden-lg hidden-md row">
  <div class="col-xs-12">
<h1 class="uso-brand-detail-mobiletitle"><a class="backLink brandColor" href="../index.html"><i class="fa fa-angle-left"></i> Efficacy</a></h1>
  </div>
 </div>
</div>
<div id="brand-detail-page" class="container-fluid brand-container">

 <div class="container">
  <div class="row mainContent">
<div class="teasers-col ">
<ul class='uso-brand-detailmenu visible-lg visible-md'>
<li>
Efficacy
</li>
<li>
<a href="../safety-profile/index.html">Safety Profile</a>
</li>
<li>
<a href="../dosing-administration/index.html">Dosing &amp; Administration</a>
</li>
<li>
<a href="../nurse-center/index.html">On-Demand Training &amp; Resources</a>
</li>
<li>
<a href="../mechanism-of-action/index.html">Mechanism of Action</a>
</li>
<li>
<a href="../access/index.html">Access</a>
</li>
<li>
<a href="../patient-resources/index.html">Patient Resources</a>
</li>
</ul>

  <div class="teasers-sticky">
<div class='left-teaser left-teaser-detail'>



<div class="quick-links-block clearfix">
 <ul>

<li>
 <a class="quick-link" href="https://www.novartis.us/sites/www.novartis.us/files/sandostatin_lar.pdf">
<span class="icon"><img  src="../../../../globalassets/download_link_icon.svg" /></span>
  <span class="quick-link-text ">Prescribing Information</span>
 </a>
</li>
<li>
 <a class="quick-link" href="https://www.us.sandostatin.com/carcinoid-syndrome">
<span class="icon"><img  src="../../../../globalassets/products/sandostatin-lar/carcinoid/list-icon-link.png" /></span>
  <span class="quick-link-text ">Visit Patient Site</span>
 </a>
</li>
<li>
 <a class="quick-link" href="http://usoncohcp-admin.stage.novartis.episerverhosting.com/link/70abc9df0e1840aeaebe563e377df611.aspx?id=10721">
<span class="icon"><img  src="../../../../globalassets/products/sandostatin-lar/carcinoid/list-icon-talk.png" /></span>
  <span class="quick-link-text ">Training &amp; Resources</span>
 </a>
</li>
<li>
 <a class="quick-link" href="http://usoncohcp-admin.stage.novartis.episerverhosting.com/link/d9831d78f7984e00adcf3b73fd501c38.aspx?id=70255">
<span class="icon"><img  src="../../../../globalassets/products/sandostatin-lar/carcinoid/list-icon-pay.png" /></span>
  <span class="quick-link-text ">Patient Services</span>
 </a>
</li> </ul>
</div>
</div>
<div class='left-teaser left-teaser-detail'>

<div class="quick-info-teaser-ISI">
 <div>
<strong class="brandColor">Important Safety Information</strong>

<div class="content">
 <p><strong>Warnings and Precautions</strong> Gallbladder abnormalities may occur. There have been postmarketing reports of cholelithiasis (gallstones) resulting in complications, including cholecystitis, cholangitis, ...</p>
</div>

  <a href="index.html#important-safety-info" class="isiLink isiLinkSUB">
<strong class="brandColor">See More</strong>
  </a>
 </div>
</div>




</div>

  </div>
 <div class="teasers">
<div class='left-teaser left-teaser-detail'>

<div class="quick-info-teaser-block-indication">

<p><strong class="brandColor">Indication</strong> Sandostatin<sup>®</sup> LAR Depot (octreotide acetate) for injectable suspension is indicated for long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors and long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors in patients in whom initial treatment with immediate-release <span style="white-space: nowrap;">Sandostatin<sup>®</sup> (octreotide acetate)</span> Injection has been shown to be effective and tolerated. In patients with carcinoid syndrome and VIPomas, the effect of Sandostatin Injection and Sandostatin LAR Depot on tumor size, rate of growth, and development of metastases has not been determined.</p>
</div>
</div>

 </div>
</div>

<div class="content-col col-lg-8 col-md-7 col-sm-12 col-xs-12">
 <div class="uso-brand-detail-main">
  <h1  class="hidden-xs hidden-sm brandColor">Efficacy</h1>
<ul class='uso-tab-menu clearfix'>
<li>
<a data-target='reduction-in-severe-diarrhea'>Reduction in Severe Diarrhea</a>
</li>
<li>
<a data-target='reduction-in-flushing'>Reduction in Flushing</a>
</li>
<li>
<a data-target='reduction-in-5-hiaa'>Reduction in 5-HIAA</a>
</li>
<li>
<a data-target='study-design'>Study Design</a>
</li>
<li>
<a data-target='case-based-conversation'>Case-Based Conversation</a>
</li>
</ul>

  <div class="uso-brand-details"><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <p>&nbsp;</p>
<p>Sandostatin<sup>®</sup> LAR Depot (octreotide acetate) for injectable suspension for treatment of the severe diarrhea and flushing associated with metastatic carcinoid tumors</p>
</div></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71783" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71783 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71783 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71783 .desktopImg { display: none; }  #image-full-half-block-71783 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_header_banner_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_header_banner_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <h4><strong>Deliver Control with Sandostatin LAR Depot</strong></h4>
<p>&nbsp;</p>
</div></div><div class="uso-brand-detailcontent">



<a name='reduction-in-severe-diarrhea'></a>
<main>
	


<h3  class="brandColor">Reduction in Severe Diarrhea</h3>

<h4 ></h4>

<div class="description">
 <p ><h4><strong>Reduction in severe diarrhea through week 24<sup>2,3<br /></sup></strong></h4></p>
</div>

<div class="content">
 
</div>




<div class="row">

 


</div>



















</main></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71774" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71774 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71774 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71774 .desktopImg { display: none; }  #image-full-half-block-71774 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_diarrhea_chart_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_diarrhea_chart_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71775" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71775 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71775 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71775 .desktopImg { display: none; }  #image-full-half-block-71775 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_diarrhea_callout_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_diarrhea_callout_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">



<a name='reduction-in-flushing'></a>
<main>
	


<h3  class="brandColor">Reduction in Flushing</h3>

<h4 ></h4>

<div class="description">
 <p ><h4><strong>Reduction in flushing episodes through week 24<sup>2,3</sup></strong></h4></p>
</div>

<div class="content">
 
</div>




<div class="row">

 


</div>



















</main></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71778" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71778 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71778 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71778 .desktopImg { display: none; }  #image-full-half-block-71778 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_flushing_chart_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_flushing_chart_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71779" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71779 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71779 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71779 .desktopImg { display: none; }  #image-full-half-block-71779 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_flushing_callout_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_flushing_callout_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <p>&nbsp;</p>
<h4><strong>HIGHLIGHTS OF IMPORTANT SAFETY INFORMATION</strong></h4>
<p>&nbsp;</p>
<p><strong>Warnings and Precautions:</strong> Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of cholelithiasis (gallstones) resulting in complications; glucose metabolism; thyroid and cardiac function; and nutritional absorption (periodic monitoring is recommended). Cardiac function: use with caution in at-risk patients.</p>
<p>Please see study design details below.</p>
<p>&nbsp;</p>
</div></div><div class="uso-brand-detailcontent">



<a name='reduction-in-5-hiaa'></a>
<main>
	


<h3  class="brandColor">Reduction in 5-HIAA</h3>

<h4 ></h4>

<div class="description">
 <p ><h4><strong>Reduction in 5-HIAA levels through week 24<sup>2,3</sup></strong></h4></p>
</div>

<div class="content">
 
</div>




<div class="row">

 


</div>



















</main></div><div class="uso-brand-detailcontent">



<div id="image-full-half-block-71780" class="image-full-half-block" data-hvce="" data-hvce-description="">
 <style>
		#image-full-half-block-71780 .desktopImg {
			display: inline-block;
		}

  #image-full-half-block-71780 .mobileImg {
			display: none;
		}

@media screen and (max-width: 1023px) { #image-full-half-block-71780 .desktopImg { display: none; }  #image-full-half-block-71780 .mobileImg {display: block;}} </style>


  <h3  class="brandColor"></h3>
  <div class="content">

  </div>

<div class="img-container">
 <img class="img-responsive desktopImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_5-hiaa_chart_d.jpg" />
  <img class="img-responsive mobileImg" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_efficacy_charts_v2_5-hiaa_chart_m.jpg" />
 </div>
</div></div><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <p class="reference">5-HIAA, 5-hydroxyindoleacetic acid.</p>
<p class="reference"><sup>a</sup>5-HIAA reductions are within the range reported in published literature for patients treated with octreotide (10%-50%).</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</div></div><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <h4 style="margin-bottom: 10px;"><strong>Learn More About the Importance of 5-HIAA</strong></h4>
<p>5-HIAA is a critical marker of carcinoid syndrome.<sup>4-6</sup> Learn more about 5-HIAA testing and why suppressing 5-HIAA levels is important.</p>
</div></div><div class="uso-brand-detailcontent">


<div class="uso-downloadable-content uso-cpyblk-content clearfix" data-hvce="" data-hvce-description="">
 <figure class="hidden-xs hidden-sm "><img alt="" src="../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_5-hiaa-brochure_thumbnail.jpg" height="122" width="122"></figure>
 <div>
  <h4></h4>
  <p></p>
  <p><a class="btn-link uso-cpyblk-link download" target="_blank" href="http://usoncohcp-admin.stage.novartis.episerverhosting.com/globalassets/products/sandostatin-lar/carcinoid/sds-1212898_sandostatin_5-hiaa_digitalpdf.pdf" >Download 5-HIAA PDF</a></p>
 </div>
</div></div><div class="uso-brand-detailcontent">



<a name='study-design'></a>
<main>
	


<h3  class="brandColor">Study Design</h3>

<h4 ></h4>

<div class="description">
 <p ><p>A 6-month clinical trial of malignant carcinoid syndrome was performed in patients who had previously been shown to be responsive to Sandostatin<sup>®</sup> (octreotide acetate) Immediate-Release Injection. Patients received 10-mg, 20-mg, or 30-mg doses of Sandostatin LAR Depot every 28 days or continued their Sandostatin Immediate-Release Injection regimen. Patients receiving Sandostatin LAR Depot who experienced symptom flare-ups were permitted to use supplemental Sandostatin Immediate-Release Injection until symptoms were again controlled to screening frequency.<sup>2,3</sup></p></p>
</div>

<div class="content">
 
</div>




<div class="row">

 


</div>



















</main></div><div class="uso-brand-detailcontent">



<a name='case-based-conversation'></a>
<main>
	


<h3  class="brandColor">Case-Based Conversation</h3>

<h4 ></h4>

<div class="description">
 <p ><p>Sandy Kotiah, MD, and Eric Liu, MD, FACS, share their expert viewpoints on the key symptoms of carcinoid syndrome, biomarker testing, differential diagnosis, and treatment with Sandostatin LAR Depot.</p></p>
</div>

<div class="content">
 
</div>




<div class="row">

 


</div>



















</main></div><div class="uso-brand-detailcontent">



<a name=''></a>
<main>
	

<h3  class="brandColor"></h3>

<h4 ></h4>

<p ></p>





 <div class="video-player-wrapper Kaltura optitle" data-hvce="" data-hvce-description="">
<div class="video-player-thumbnail" id="video-thumb-71870" style="background-image: url(../../../../globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_expert_option_video_thumb.jpg)">
 <a class="video-play-icon"><span class="play-icon">h</span></a>
</div>
  <div id="1561108653" class="uso-brand-detail-player" data-targetId="1561108653-player" data-wid="_2076321" data-playerId="kaltura_player_1561108653" data-partnerId="2076321" data-uiconfId="40166251" data-entryId="1_c5m3ycn4" data-kalturaCss="" data-thumbnailUrl="/globalassets/products/sandostatin-lar/carcinoid/efficacy/110550_expert_option_video_thumb.jpg"  data-brandTheme="/modules/KalturaPlayerBrandColors/?BrandColor=19a2b1"  data-videoName="Case-based conversations">
<div class="inner">
 <div id="1561108653-player" class="embed-responsive embed-responsive-16by9"></div>
</div>
  </div>
 </div>
 <script id="KalturaScript" src="http://cdnapisec.kaltura.com/p/2076321/sp/207632100/embedIframeJs/uiconf_id/40166251/partner_id/2076321"></script>







<div class="row">

 


</div>


</main></div><div class="uso-brand-detailcontent">
<div class="uso-cpyblk-content">
 <p class="reference"><strong>References:</strong> <strong>1.</strong> Data on file. Novartis Pharmaceuticals Corp; March 2019. <strong>2.</strong> Sandostatin LAR Depot [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2019. <strong>3.</strong> Rubin J, Ajani J, Schirmer W, et al. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. <em>J Clin Oncol</em>. 1999;17(2):600-606. <strong>4.</strong> Creutzfeldt W. Carcinoid tumors: development of our knowledge. <em>World J Surg</em>. 1996;20(2):126-131. <strong>5.</strong> McCormick D. Carcinoid tumors and syndrome. <em>Gastroenterol Nurs</em>. 2002;25(3):105-111. <strong>6.</strong> Öberg K. Carcinoid tumors, carcinoid syndrome, and related disorders. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. <em>Williams Textbook of Endocrinology</em>. 10th ed. Philadelphia, PA: WB Saunders Company; 2003:1857-1876.</p>
</div></div></div>
 </div>
</div>
<div class="col-isi-content stop-sticky">
  <div class="row">
<div class="col-lg-12">
 <a name="important-safety-info" class="internalAnchor"></a>
 <p class="brandColor"><strong>IMPORTANT SAFETY INFORMATION</strong></p>
<p><strong>Warnings and Precautions</strong></p>
<ul>
<li>Gallbladder abnormalities may occur. There have been postmarketing reports of cholelithiasis (gallstones) resulting in complications, including cholecystitis, cholangitis, pancreatitis, and requiring cholecystectomy in patients taking Sandostatin LAR Depot. Patients should be monitored periodically. If complications of cholelithiasis are suspected, discontinue Sandostatin LAR Depot and treat appropriately</li>
<li>Glucose Metabolism: Hypoglycemia or hyperglycemia may occur. Blood glucose levels should be monitored when Sandostatin LAR Depot treatment is initiated or when the dose is altered. Antidiabetic treatment should be adjusted accordingly</li>
<li>Thyroid Function: Hypothyroidism may occur. Baseline and periodic assessment of thyroid function (TSH, total and/or free T4) is recommended</li>
<li>Cardiac Function: Bradycardia, arrhythmia, conduction abnormalities, and other ECG changes may occur. The relationship of these events to octreotide acetate is not established because many of these patients have underlying cardiac disease. Use with caution in at-risk patients</li>
<li>Nutrition: Octreotide may alter absorption of dietary fats. Monitoring of vitamin B<sub>12</sub> levels is recommended during therapy with Sandostatin LAR Depot. Patients on total parenteral nutrition (TPN) and octreotide should have periodic monitoring of zinc levels</li>
</ul>
<p><strong>Drug Interactions</strong></p>
<ul>
<li>The following drugs require monitoring and possible dose adjustment when used with Sandostatin LAR Depot: cyclosporine, insulin, oral hypoglycemic agents, beta-blockers, and bromocriptine. Octreotide has been associated with alterations in nutrient absorption, so it may have an effect on absorption of orally administered drugs. Drugs mainly metabolized by CYP3A4 and which have a low therapeutic index should be used with caution</li>
</ul>
<p><strong>Adverse Reactions</strong></p>
<ul>
<li>The most common adverse reactions occurring in patients receiving Sandostatin LAR Depot were biliary abnormalities (62%), injection-site pain (20%-50%), nausea (24%-41%), abdominal pain (10%-35%), fatigue (8%-32%), headache (16%-30%), hyperglycemia (27%), back pain (8%-27%), constipation or vomiting (15%-21%), dizziness (18%-20%), sinus bradycardia (19%), pruritus (18%), upper respiratory tract infection (10%-18%), myalgia (4%-18%), flatulence (9%-16%), arthropathy (8%-15%), rash (15%), generalized pain (4%-15%), sinusitis (5%-12%), conduction abnormalities (9%), hypoglycemia (4%), and arrhythmia (3%)</li>
</ul>
<p><strong>Please see full <a href="https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/sandostatin_lar.pdf" target="_blank" rel="nofollow" data-target="none">Prescribing Information</a>.</strong></p>
<p class="brandColor"><strong>Indications and Usage</strong></p>
<p>Sandostatin<sup>®</sup> LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin<sup>®</sup> (octreotide acetate) Injection has been shown to be effective and tolerated for</p>
<ul>
<li>Long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors</li>
<li>Long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors</li>
</ul>
<p>In patients with carcinoid syndrome and VIPomas, the effect of Sandostatin Injection and Sandostatin LAR Depot on tumor size, rate of growth, and development of metastases has not been determined.</p>
</div>
  </div>


</div>
<div class="col-xs-12">
<ul class='uso-brand-detailmenu mobile visible-xs'>
<li>
Efficacy
</li>
<li>
<a href="../safety-profile/index.html">Safety Profile</a>
</li>
<li>
<a href="../dosing-administration/index.html">Dosing &amp; Administration</a>
</li>
<li>
<a href="../nurse-center/index.html">On-Demand Training &amp; Resources</a>
</li>
<li>
<a href="../mechanism-of-action/index.html">Mechanism of Action</a>
</li>
<li>
<a href="../access/index.html">Access</a>
</li>
<li>
<a href="../patient-resources/index.html">Patient Resources</a>
</li>
</ul>

</div>

  </div>
<div class="row">
 <div class="col-lg-12 col-md-12">

 </div>
</div>
 </div>
</div>

		</div>
		<div class="container-fluid">
			<div class="row">
				<div>
					<div class="uso-back-to-top hidden-lg text-center">
						<a href="index.html#" onclick="scrollWinTop()"><img src="../../../../Static/img/global/uso-icon-back-to-top.png" /></a> <br />
						<a href="index.html#" onclick="scrollWinTop()" class="uso-btt-link">BACK TO TOP</a>
					</div>
					<div class="uso-back-to-top-lg hidden"></div>
				</div>
			</div>
		</div>
	</main>
	<div><div>
<div style="" class="stop-sticky container-fluid uso-footer">
 <div class="container">
  <div class="row">
<div class="col-lg-12 text-center">
 <div class="uso-ftr-social">
  
  
 </div>
 <div class="uso-ftr-links">
  <p><a class="btn btn-link" href="https://medinfo.novartispharmaceuticals.com/" target="_blank" rel="nofollow" data-target="none">Medical Information</a>&nbsp;<span class="divider">|</span>&nbsp;<a class="btn btn-link" href="https://www.hcp.novartis.com/contact" target="_blank" rel="nofollow" data-target="none">Contact Us</a>&nbsp;<span class="divider">|</span>&nbsp;<a class="btn btn-link" href="http://www.sandostatin.com?non-us" target="_blank" rel="nofollow" data-target="none">Non-US Residents</a>&nbsp;<span class="divider">|</span>&nbsp;<a class="btn btn-link" href="https://www.novartis.us/hcp-privacy-policy#anchor" target="_blank" rel="nofollow" data-target="none">Interest-based Ads</a></p>

 </div>
</div>
  </div>
  <div class="row">
 
<div class="col-lg-6 text-left center-tablet-phone">
 <div class="uso-ftr-logo">
  <a href="https://www.novartis.us/about-us" title="Novartis Oncology" target="_blank" data-target="none"><img src="../../../../globalassets/novartis-logo-111516.svg" alt="Novartis Oncology"></a>
 </div>
</div>
  </div>

  <div class="row">
<div class="col-lg-12 text-left center-tablet-phone">
 <div class="uso-ftr-disclaimer">
  <p>Use of website is governed by the&nbsp;<strong><a class="btn btn-link" href="https://www.novartis.us/terms-use" target="_blank" rel="nofollow" data-target="none">Terms of Use</a></strong>&nbsp;and&nbsp;<strong><a class="btn btn-link" href="https://www.novartis.us/hcp-privacy-policy" target="_blank" rel="nofollow" data-target="none">Privacy Policy</a></strong>.</p>
 </div>
 
</div>
  </div>
  <div class="row">
<div class="col-lg-6 col-xs-12 text-left center-tablet-phone">
 <div class="uso-ftr-copyright">
  <p>Copyright © 2020&nbsp;<a class="btn btn-link" href="https://www.novartis.us/about-us" target="_blank" rel="nofollow" data-target="none">Novartis Pharmaceuticals Corporation</a>. All rights reserved.</p>
 </div>
</div>

<div class="col-lg-6 col-xs-12 text-right center-tablet-phone">
 <div class="uso-ftr-code">
  5/20 SDS-1230251
 </div>
</div>
  </div>
 </div>
</div>

<div id="termsOfuseModal" class="modal fade">
 <div class="modal-dialog">
  <div class="modal-content">
<div class="modal-body">
 
</div>
  </div>
 </div>
</div>

<div id="privacyPolicyModal" class="modal fade">
 <div class="modal-dialog">
  <div class="modal-content">
<div class="modal-body">
 
</div>
  </div>
 </div>
</div></div></div>

	<script src="../../../../bundles/script/master%3Fv=IgwyWqHAVMW8mZv43JHre8PsGfwvmO76Tt124V1TBDo1"></script>


	
 <script src="../../../../bundles/script/brands%3Fv=35NHaC3i5xK1MiMzsewDx66lvpjLyMB4aSozWPFmjmg1"></script>



	<script>
		function scrollWinTop() {
			$(window).scrollTo(0, 500);
			return false;
		}
	</script>
	<div class="container">
		<a href="index.html#" id="uso-sticky-back"><i class="fa fa-angle-up"></i></a>
	</div>



				<div id="interstitialPopUp" class="modal fade">
					<div class="modal-dialog">
						<div class="modal-content">
							<div class="modal-header">
								<button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
								<img class="center-block novartis-logo" src="../../../../Static/img/global/Novartis-Logo.svg" />
							</div>
							<div class="modal-body">
								<p>You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.</p>
							</div>
							<div class="modal-footer">
								<div class="text-center">
									<a class="btn btn-default btn-cancel" data-dismiss="modal"><span>Cancel</span></a>
									<a class="btn btn-continue interstitialOKButton" id="" href="index.html#">OK</a>
								</div>
									<div class="disclaimer-omap">
										1/17  ONC-1154329
									</div>
							</div>
						</div>
					</div>
				</div>


		
</body>





</html>
